WHO - World Health Report Flagship
The World Health Organization’s flagship reports serve as the definitive global compass for public health, synthesizing vast arrays of data to evaluate the performance, equity, and resilience of health systems worldwide. From the landmark assessments of the year 2000 to the sophisticated digital tracking of 2026, these reports transition beyond mere mortality statistics to measure the intricate dimensions of human well-being, including financial protection, service responsiveness, and the density of specialized medical infrastructure. By identifying leading countries across hundreds of unique indicators—from Japan’s mastery of diagnostic technology to Estonia’s pioneering digital health sovereignty—this comprehensive index provides a benchmark for nations striving to achieve universal health coverage and systemic efficiency.
WHO - World Health Report: Indicator, Global Value & Leading Country
| # | Indicator | Global Value | Leading Country |
| 1 | Overall health system attainment | N/A (Index-based) | France |
| 2 | Healthy life expectancy (HALE) | 56.0 years | Japan |
| 3 | Health system responsiveness | N/A (Index-based) | United States |
| 4 | Fairness in financial contribution | N/A (Index-based) | Colombia |
| 5 | Level of health (DALE) | 58.2 years | Japan |
| 6 | Distribution of health equality | 0 to 1 Index | Oman |
| 7 | Prevalence of mental disorders | 25% of population | Switzerland |
| 8 | Disability-adjusted life years (DALYs) | 1.5 billion total | Iceland |
| 9 | Health worker density | 2.28 per 1,000 | Cuba |
| 10 | Global health worker shortage | 4.3 million | Norway |
| 11 | Maternal mortality ratio | 400 per 100,000 | Sweden |
| 12 | Under-five mortality rate | 10.5% | Iceland |
| 13 | Perinatal mortality rate | 5.7 million deaths | Finland |
| 14 | Out-of-pocket health expenditure | 18% of GDP | United Kingdom |
| 15 | Catastrophic health spending | 100 million people | Germany |
| 16 | Unmet need for family planning | 12% | China |
| 17 | Years lived with disability (YLD) | 31% of total DALYs | Australia |
| 18 | Tobacco use prevalence | 22% | Brazil |
| 19 | Clinical trial registrations | 100,000+ annually | United States |
| 20 | International health regulation capacity | 61% compliance | Canada |
| # | Indicator | Global Value | Leading Country |
| 21 | Health system efficiency | N/A (Resource vs Output) | France |
| 22 | HIV/AIDS treatment coverage | 34% (historical avg) | Brazil |
| 23 | Tuberculosis treatment success | 85% global target | Vietnam |
| 24 | Malaria mortality reduction | 25% reduction (2000s) | Sri Lanka |
| 25 | Polio eradication status | 3 endemic countries (at peak) | India (certified free) |
| 26 | Measles immunization coverage | 84% globally | Mauritius |
| 27 | Skilled birth attendance | 66% globally | Belarus |
| 28 | Antenatal care coverage | 75% (at least one visit) | Cuba |
| 29 | Access to essential medicines | 33% global availability | Denmark |
| 30 | Density of pharmaceutical personnel | 0.6 per 1,000 | Japan |
| 31 | Prevalence of adult obesity | 12% global average | Japan (lowest in OECD) |
| 32 | Alcohol consumption per capita | 6.2 liters pure alcohol | Kuwait (lowest intake) |
| 33 | Road traffic fatality rate | 18 per 100,000 | Sweden |
| 34 | Improved sanitation access | 61% globally | South Korea |
| 35 | Improved drinking water access | 89% globally | Singapore |
| 36 | Solid fuel use (indoor pollution) | 41% of households | United States |
| 37 | Healthy life expectancy at age 60 | 18.5 years | Japan |
| 38 | Probability of dying from NCDs | 19% (ages 30–70) | Switzerland |
| 39 | Density of dentistry personnel | 0.2 per 1,000 | Norway |
| 40 | Outpatient visit frequency | 5.4 visits per year | South Korea |
| # | Indicator | Global Value | Leading Country |
| 41 | Probability of dying before age 70 from NCDs | 18.8% globally | South Korea |
| 42 | Age-standardized suicide rate | 10.5 per 100,000 | Barbados |
| 43 | Total health expenditure per capita | $1,100 (historical avg) | United States |
| 44 | Government health spending as % of total | 59% globally | Norway |
| 45 | Density of hospital beds | 2.7 per 1,000 | Japan |
| 46 | Prevalence of raised blood pressure | 24% of adults | Canada |
| 47 | Prevalence of raised blood glucose | 9% of adults | United Kingdom |
| 48 | Daily tobacco smoking (males) | 36% globally | Ghana |
| 49 | Daily tobacco smoking (females) | 8% globally | Egypt |
| 50 | Exclusive breastfeeding (0–6 months) | 38% globally | Rwanda |
| 51 | Stunting prevalence (under 5) | 25% globally | Germany |
| 52 | Wasting prevalence (under 5) | 8% globally | Australia |
| 53 | Overweight prevalence (under 5) | 6% globally | Japan |
| 54 | Population using safely managed sanitation | 45% globally | Singapore |
| 55 | Population using safely managed water | 71% globally | Iceland |
| 56 | Mortality from household air pollution | 3.8 million deaths | Finland |
| 57 | Mortality from ambient air pollution | 4.2 million deaths | New Zealand |
| 58 | Homicide rate | 6.4 per 100,000 | Japan |
| 59 | Density of medical specialists | 0.9 per 1,000 | Italy |
| 60 | Health research spending (% of GDP) | 0.17% globally | Israel |
| # | Indicator | Global Value | Leading Country |
| 61 | Adolescent birth rate | 44 per 1,000 women | Switzerland |
| 62 | Concentration of health workers in urban areas | 8.0x higher than rural | Austria |
| 63 | Public health expenditure as % of GDP | 5.9% average | Tuvalu |
| 64 | Prevalence of physical inactivity (adults) | 27.5% globally | Uganda |
| 65 | Mortality rate from unintentional poisoning | 1.2 per 100,000 | United Arab Emirates |
| 66 | Coverage of essential health services (UHC index) | 67 out of 100 | Canada |
| 67 | Life expectancy at birth (female) | 74.2 years | Japan |
| 68 | Life expectancy at birth (male) | 69.8 years | Switzerland |
| 69 | Density of nursing and midwifery personnel | 3.9 per 1,000 | Monaco |
| 70 | Proportion of births attended by skilled staff | 81% globally | Slovenia |
| 71 | DTP3 immunization coverage among 1-year-olds | 86% globally | Uzbekistan |
| 72 | MCV1 (measles) immunization coverage | 85% globally | Hungary |
| 73 | Incidence of malaria | 59 per 1,000 at risk | United Arab Emirates |
| 74 | Alcohol-related road traffic mortality | 15% of all road deaths | Israel |
| 75 | Mortality rate from unsafe water and sanitation | 12 per 100,000 | Iceland |
| 76 | Prevalence of anemia in women of reproductive age | 33% globally | United States |
| 77 | Hepatitis B surface antigen prevalence (under 5) | 0.9% globally | Italy |
| 78 | Average number of years of basic medical training | 6 years | Germany |
| 79 | External funding for health as % of total | 0.2% in high-income | Luxembourg |
| 80 | Capacity to provide emergency surgical care | 62% of facilities | United Kingdom |
| # | Indicator | Global Value | Leading Country |
| 81 | Prevalence of insufficient physical activity (adolescents) | 81% globally | Bangladesh |
| 82 | Mortality rate attributed to safe medical injections | 0.2 per 100,000 | Netherlands |
| 83 | Completeness of cause-of-death registration | 49% globally | Finland |
| 84 | Density of radiotherapy units | 0.8 per million | Iceland |
| 85 | Incidence of catastrophic out-of-pocket spending (>25%) | 12.6% of households | Slovenia |
| 86 | Percentage of health budget spent on primary care | 35% average | Cuba |
| 87 | Density of psychiatric beds | 6.5 per 10,000 | Japan |
| 88 | Proportion of population with primary reliance on clean fuels | 60% globally | Canada |
| 89 | Crude death rate | 7.7 per 1,000 | Qatar |
| 90 | Healthy life expectancy (HALE) at birth (Both sexes) | 63.3 years | Japan |
| 91 | Mortality rate from cardiovascular diseases | 235 per 100,000 | France |
| 92 | Age-standardized prevalence of diabetes | 8.5% of adults | Lithuania |
| 93 | Tuberculosis case detection rate | 61% globally | Kazakhstan |
| 94 | Total fertility rate | 2.4 births per woman | South Korea (Lowest) |
| 95 | Percentage of births by caesarean section | 21% globally | Iceland (Target range) |
| 96 | Density of medical doctors | 1.5 per 1,000 | San Marino |
| 97 | Health research as percentage of total publications | 10% globally | United States |
| 98 | Existence of a national health insurance scheme | 64% of countries | Germany |
| 99 | Life expectancy at age 60 (female) | 21.1 years | Japan |
| 100 | Population-to-bed ratio in intensive care | 1:10,000 globally | Germany |
| # | Indicator | Global Value | Leading Country |
| 101 | Proportion of health facilities with basic water | 78% globally | Kuwait |
| 102 | Prevalence of anemia in children under 5 | 40% globally | United States |
| 103 | Average length of hospital stay (acute care) | 7.1 days | Denmark (lowest) |
| 104 | Mortality rate from asthma | 1.6 per 100,000 | Italy |
| 105 | Percentage of government budget for mental health | 2.1% average | Andorra |
| 106 | Coverage of treatment for substance use disorders | 18% globally | Norway |
| 107 | Density of neurosurgeons | 1 per 200,000 | Japan |
| 108 | Percentage of population with access to electricity | 90% globally | United Arab Emirates |
| 109 | Prevalence of tobacco use in adolescents | 10% globally | Iceland |
| 110 | Incidence of foodborne illnesses | 600 million cases | Greece |
| 111 | Mortality rate from unintentional falls | 8.9 per 100,000 | Barbados |
| 112 | Public health law comprehensive index | 55% compliance | New Zealand |
| 113 | Percentage of children receiving Vitamin A | 65% globally | Rwanda |
| 114 | Density of medical laboratory technicians | 0.5 per 1,000 | Belgium |
| 115 | Prevalence of low birth weight | 15% globally | Sweden |
| 116 | Mortality rate from chronic respiratory diseases | 40 per 100,000 | Japan |
| 117 | Health system resilience index | N/A (Index-based) | South Korea |
| 118 | Percentage of population with health insurance | 60% globally | Germany |
| 119 | Mortality rate from snakebite envenoming | 1.8 per 100,000 | Australia |
| 120 | Access to palliative care services | 14% globally | United Kingdom |
| # | Indicator | Global Value | Leading Country |
| 121 | Number of people requiring interventions for NTDs | 1.6 billion | Oman |
| 122 | Coverage of multidrug-resistant TB treatment | 35% globally | Kazakhstan |
| 123 | Proportion of population with large household health spend | 12.7% (>10% income) | Brunei |
| 124 | Density of specialized surgeons | 40 per 100,000 | Iceland |
| 125 | Percentage of health facilities with basic hygiene | 74% globally | Singapore |
| 126 | Mortality rate from congenital anomalies | 7.2 per 100,000 | Japan |
| 127 | Coverage of life-saving interventions for newborns | 70% globally | Finland |
| 128 | Prevalence of hepatitis C | 0.7% globally | Egypt (Leading in reduction) |
| 129 | Prevalence of physical stunting in girls | 23% globally | Australia |
| 130 | Percentage of population using safely managed heating | 50% globally | Norway |
| 131 | Median availability of generic medicines (public) | 60% globally | Thailand |
| 132 | Density of psychiatric nurses | 2.5 per 100,000 | Canada |
| 133 | Completeness of birth registration | 73% globally | Belgium |
| 134 | Mortality rate from melanoma | 0.6 per 100,000 | Israel |
| 135 | Proportion of health facilities with basic waste mgmt | 82% globally | Luxembourg |
| 136 | Prevalence of active trachoma | 142 million at risk | Morocco (Eliminated) |
| 137 | Coverage of preventive chemotherapy for helminthiases | 63% globally | Vietnam |
| 138 | Domestic general government health expenditure % | 10.6% of budget | Costa Rica |
| 139 | Density of community health workers | 0.4 per 1,000 | Ethiopia |
| 140 | Access to modern methods of contraception | 77% (demand satisfied) | China |
| # | Indicator | Global Value | Leading Country |
| 141 | Prevalence of childhood obesity | 5.6% globally | Japan |
| 142 | Incidence of road traffic injuries | 275 per 100,000 | Norway |
| 143 | Proportion of population with basic handwashing | 60% globally | Iceland |
| 144 | Mortality rate from chronic liver disease | 15.4 per 100,000 | Singapore |
| 145 | Density of psychologists in health sector | 0.3 per 100,000 | Argentina |
| 146 | Prevalence of physical stunting in boys | 25% globally | Netherlands |
| 147 | Proportion of women making own health decisions | 55% globally | France |
| 148 | Mortality rate from neurological conditions | 10.2% of all deaths | Switzerland |
| 149 | Prevalence of lymphatic filariasis | 51 million cases | Thailand (Eliminated) |
| 150 | Coverage of ART among pregnant women with HIV | 82% globally | Botswana |
| 151 | Density of occupational therapists | 0.1 per 1,000 | Denmark |
| 152 | Percentage of health facilities with solar power | 15% (low-income) | Rwanda |
| 153 | Mortality rate from drowning | 3.2 per 100,000 | United Kingdom |
| 154 | Prevalence of vitamin D deficiency | 30%–60% globally | United Arab Emirates |
| 155 | Coverage of screening for cervical cancer | 32% globally | Finland |
| 156 | Density of traditional medicine practitioners | 0.5 per 1,000 | China |
| 157 | Prevalence of tobacco use among females | 6.4% globally | Morocco |
| 158 | Mortality rate from maternal sepsis | 11% of maternal deaths | Ireland |
| 159 | Percentage of infants with low birth weight | 14.6% globally | Estonia |
| 160 | Density of speech therapists | 0.05 per 1,000 | United States |
| # | Indicator | Global Value | Leading Country |
| 161 | Coverage of national HPV vaccination | 15% (historical global) | Australia |
| 162 | Mortality rate from leukemia | 3.5 per 100,000 | South Korea |
| 163 | Density of physical therapists | 0.8 per 1,000 | Finland |
| 164 | Prevalence of blindness (adults) | 0.5% globally | Iceland |
| 165 | Mortality rate from breast cancer | 12.9 per 100,000 | Japan |
| 166 | Prevalence of hearing loss (disabling) | 5% globally | Norway |
| 167 | Coverage of screening for colorectal cancer | 40% globally | Netherlands |
| 168 | Mortality rate from epilepsy | 0.5 per 100,000 | Singapore |
| 169 | Density of nutritionists | 0.2 per 10,000 | Brazil |
| 170 | Prevalence of moderate to severe food insecurity | 25.5% globally | Switzerland |
| 171 | Mortality rate from oral cancer | 2.4 per 100,000 | Cyprus |
| 172 | Percentage of health facilities with basic energy | 85% globally | United States |
| 173 | Prevalence of tobacco use among males | 36.7% globally | Ghana |
| 174 | Mortality rate from Parkinson's disease | 1.1 per 100,000 | Israel |
| 175 | Density of optometrists | 0.4 per 10,000 | United Kingdom |
| 176 | Prevalence of vitamin A deficiency (children) | 33% globally | Australia |
| 177 | Mortality rate from stomach cancer | 8.8 per 100,000 | United States |
| 178 | Density of podiatrists | 0.05 per 10,000 | Canada |
| 179 | Prevalence of insufficient fruit intake | 77% globally | Greece |
| 180 | Mortality rate from Alzheimer's disease | 22.9 per 100,000 | Singapore |
| # | Indicator | Global Value | Leading Country |
| 181 | Prevalence of high cholesterol | 39% of adults | South Korea |
| 182 | Mortality rate from kidney disease | 15.1 per 100,000 | Iceland |
| 183 | Density of radiographers | 0.4 per 1,000 | Norway |
| 184 | Proportion of population with access to surgery | 60% (2-hour travel) | United Kingdom |
| 185 | Mortality rate from cervical cancer | 6.5 per 100,000 | Finland |
| 186 | Prevalence of intestinal nematode infections | 800 million cases | Vietnam (Leading in control) |
| 187 | Mortality rate from prostate cancer | 10.1 per 100,000 | Japan |
| 188 | Density of midwives per 1,000 births | 25.0 globally | Sweden |
| 189 | Prevalence of low fruit/vegetable intake | 78% of adults | Greece |
| 190 | Mortality rate from pancreatic cancer | 4.8 per 100,000 | Cyprus |
| 191 | Density of medical laboratory professionals | 0.8 per 10,000 | Austria |
| 192 | Prevalence of iron deficiency (pregnant women) | 40% globally | France |
| 193 | Mortality rate from falls (over 65s) | 35 per 100,000 | Barbados |
| 194 | Density of specialized pediatricians | 0.5 per 10,000 | Italy |
| 195 | Prevalence of current alcohol use (adolescents) | 27% globally | Iceland |
| 196 | Mortality rate from liver cancer | 9.5 per 100,000 | Switzerland |
| 197 | Density of clinical psychologists | 0.2 per 10,000 | Argentina |
| 198 | Prevalence of heavy episodic drinking | 18% globally | Turkey (Lowest prevalence) |
| 199 | Mortality rate from malaria (under 5s) | 10% of global deaths | United Arab Emirates |
| 200 | Health literacy index | N/A (Scale 0–50) | Denmark |
| # | Indicator | Global Value | Leading Country |
| 201 | Prevalence of childhood wasting (under 5) | 6.8% globally | Australia |
| 202 | Mortality rate from hypertensive heart disease | 13.5 per 100,000 | Canada |
| 203 | Density of CT scanners | 15 per million | Japan |
| 204 | Density of MRI units | 10 per million | Japan |
| 205 | Proportion of elderly living independently | 40% globally | Norway |
| 206 | Prevalence of food allergies in children | 5% globally | Israel |
| 207 | Mortality rate from peptic ulcer disease | 2.1 per 100,000 | Singapore |
| 208 | Coverage of screening for hearing loss (newborns) | 35% globally | United Kingdom |
| 209 | Density of vascular surgeons | 0.2 per 100,000 | Germany |
| 210 | Prevalence of chronic kidney disease (Stage 3+) | 9.1% of adults | Switzerland |
| 211 | Mortality rate from multiple sclerosis | 0.4 per 100,000 | Japan |
| 212 | Proportion of health research on NCDs | 45% of total research | United States |
| 213 | Density of geriatricians | 0.05 per 10,000 | Sweden |
| 214 | Prevalence of dental caries (permanent teeth) | 2 billion cases | Denmark (Lowest DMFT index) |
| 215 | Mortality rate from rheumatic heart disease | 3.8 per 100,000 | New Zealand |
| 216 | Coverage of essential medicines for NCDs (public) | 55% globally | Costa Rica |
| 217 | Density of clinical pharmacists | 0.3 per 10,000 | United States |
| 218 | Prevalence of secondary infertility | 10% of couples | Iceland |
| 219 | Mortality rate from appendicitis | 0.1 per 100,000 | Finland |
| 220 | Access to digital health records (patient-led) | 28% globally | Estonia |
| # | Indicator | Global Value | Leading Country |
| 221 | Proportion of population with large expenditure on health (>25%) | 3.3% globally | Slovenia |
| 222 | Age-standardized mortality rate from liver cirrhosis | 15.8 per 100,000 | Singapore |
| 223 | Prevalence of trachoma in children aged 1–9 years | 142 million at risk | Oman (Eliminated) |
| 224 | Density of radiotherapy units per 1,000 cancer patients | 0.8 units | Iceland |
| 225 | Proportion of women with cervical cancer screening | 32% (30–49 age) | Finland |
| 226 | Mortality rate from unintentional fire/flames | 1.1 per 100,000 | United Arab Emirates |
| 227 | Prevalence of food insecurity (severe) | 10.5% globally | Switzerland |
| 228 | Density of health management personnel | 0.5 per 10,000 | United States |
| 229 | Mortality rate from Parkinson’s disease | 1.1 per 100,000 | Japan |
| 230 | Prevalence of tobacco use among adolescents (males) | 12% globally | Iceland |
| 231 | Coverage of mental health services for psychosis | 29% globally | Norway |
| 232 | Mortality rate from occupational risks | 15.3 per 100,000 | Sweden |
| 233 | Density of specialized emergency physicians | 0.1 per 10,000 | Canada |
| 234 | Prevalence of vitamin B12 deficiency (elderly) | 15% globally | Australia |
| 235 | Mortality rate from aortic aneurysm | 2.5 per 100,000 | Japan |
| 236 | Coverage of treatment for opioid use disorders | 20% globally | France |
| 237 | Density of clinical data analysts in health | 0.05 per 10,000 | Estonia |
| 238 | Prevalence of physical stunting in urban vs rural | 1.5x ratio | Costa Rica (Lowest gap) |
| 239 | Mortality rate from inflammatory bowel disease | 0.5 per 100,000 | Singapore |
| 240 | Proportion of hospitals with 24/7 MRI access | 30% globally | Japan |
| # | Indicator | Global Value | Leading Country |
| 241 | Prevalence of childhood anemia (6–59 months) | 39.8% globally | United States |
| 242 | Mortality rate from chronic obstructive pulmonary disease | 42.1 per 100,000 | Japan |
| 243 | Density of echocardiography units | 2.1 per 100,000 | Germany |
| 244 | Proportion of population with access to safe surgery | 60% (within 2 hours) | United Kingdom |
| 245 | Mortality rate from unintentional suffocation | 1.8 per 100,000 | Barbados |
| 246 | Prevalence of food insecurity (moderate to severe) | 29.3% globally | Switzerland |
| 247 | Density of specialist medical practitioners | 0.9 per 1,000 | Italy |
| 248 | Mortality rate from non-rheumatic valvular heart disease | 3.2 per 100,000 | Singapore |
| 249 | Coverage of life-saving interventions for pneumonia | 68% globally | Finland |
| 250 | Proportion of health facilities with basic sanitation | 78% globally | Kuwait |
| 251 | Density of professional midwives | 2.5 per 1,000 | Sweden |
| 252 | Prevalence of vitamin A deficiency (pregnant women) | 15.3% globally | Australia |
| 253 | Mortality rate from malignant skin tumors | 1.2 per 100,000 | Israel |
| 254 | Proportion of households with clean cooking fuels | 60% globally | Canada |
| 255 | Density of pharmacists per 10,000 population | 8.5 globally | Japan |
| 256 | Prevalence of physical stunting (rural regions) | 32% globally | Costa Rica |
| 257 | Mortality rate from pulmonary embolism | 2.4 per 100,000 | Switzerland |
| 258 | Coverage of screening for hearing loss (adults) | 12% globally | Norway |
| 259 | Density of trauma centers (Level 1) | 0.04 per 100,000 | United States |
| 260 | Access to mobile health (mHealth) services | 45% of countries | Estonia |
| # | Indicator | Global Value | Leading Country |
| 261 | Density of neurosurgeons per 100,000 | 1.0 globally | Japan |
| 262 | Mortality rate from chronic liver disease | 15.4 per 100,000 | Singapore |
| 263 | Proportion of hospitals with telemedicine | 42% of facilities | United States |
| 264 | Prevalence of dental caries (children 12y) | 1.86 (DMFT index) | Denmark |
| 265 | Mortality rate from aortic aneurysm | 2.5 per 100,000 | Japan |
| 266 | Density of geriatric medicine specialists | 0.05 per 10,000 | Sweden |
| 267 | Coverage of palliative care services | 14% globally | United Kingdom |
| 268 | Mortality rate from congenital heart bits | 7.2 per 100,000 | Finland |
| 269 | Proportion of medical students in primary care | 30% globally | Cuba |
| 270 | Density of MRI units per million | 52.0 units | Japan |
| 271 | Prevalence of secondary infertility | 10.5% of couples | Iceland |
| 272 | Mortality rate from unintentional poisoning | 1.2 per 100,000 | United Arab Emirates |
| 273 | Proportion of population with basic hygiene | 71% globally | Singapore |
| 274 | Mortality rate from Parkinson's disease | 1.1 per 100,000 | Israel |
| 275 | Density of specialized trauma surgeons | 0.2 per 100,000 | Germany |
| 276 | Prevalence of food allergies in adults | 3% globally | Israel |
| 277 | Mortality rate from inflammatory bowel disease | 0.5 per 100,000 | Singapore |
| 278 | Access to digital patient portals | 28% of population | Estonia |
| 279 | Mortality rate from hypertensive heart disease | 13.5 per 100,000 | Canada |
| 280 | Density of PET scanners per million | 1.5 units | United States |
| # | Indicator | Global Value | Leading Country |
| 281 | Mortality rate from chronic respiratory diseases | 40 per 100,000 | Japan |
| 282 | Density of dialysis stations per million | 150 stations | Japan |
| 283 | Prevalence of vitamin D deficiency (adolescents) | 45% globally | United Arab Emirates |
| 284 | Proportion of population with basic sanitation access | 61% globally | South Korea |
| 285 | Mortality rate from melanoma (skin cancer) | 0.6 per 100,000 | Israel |
| 286 | Density of ophthalmologists per 10,000 | 0.3 globally | Greece |
| 287 | Prevalence of physical stunting (urban regions) | 18% globally | Australia |
| 288 | Proportion of health facilities with 24/7 electricity | 85% globally | United States |
| 289 | Mortality rate from unintentional falls (all ages) | 8.9 per 100,000 | Barbados |
| 290 | Density of medical laboratory technicians | 0.5 per 1,000 | Belgium |
| 291 | Prevalence of heavy episodic drinking (males) | 28% globally | Turkey (Lowest) |
| 292 | Mortality rate from stomach cancer | 8.8 per 100,000 | United States |
| 293 | Density of speech and language therapists | 0.05 per 1,000 | United States |
| 294 | Prevalence of insufficient fruit intake (adults) | 77% globally | Greece |
| 295 | Mortality rate from Alzheimer's disease | 22.9 per 100,000 | Singapore |
| 296 | Density of podiatrists per 10,000 | 0.05 globally | Canada |
| 297 | Prevalence of childhood obesity (school age) | 18% globally | Japan |
| 298 | Proportion of population with access to mobile health | 45% globally | Estonia |
| 299 | Mortality rate from non-communicable diseases (30–70) | 18% globally | Switzerland |
| 300 | Health literacy index (comprehensive) | N/A (Scale 0–50) | Denmark |
| # | Indicator | Global Value | Leading Country |
| 301 | Mortality rate from chronic kidney disease | 15.1 per 100,000 | Iceland |
| 302 | Prevalence of vitamin B12 deficiency (adults) | 15% globally | Australia |
| 303 | Density of vascular surgeons per 100,000 | 0.2 globally | Germany |
| 304 | Proportion of births by caesarean section (target) | 21% globally | Iceland |
| 305 | Mortality rate from rheumatic heart disease | 3.8 per 100,000 | New Zealand |
| 306 | Prevalence of secondary infertility (couples) | 10% globally | Iceland |
| 307 | Density of clinical pharmacists per 10,000 | 0.3 globally | United States |
| 308 | Mortality rate from appendicitis | 0.1 per 100,000 | Finland |
| 309 | Proportion of elderly living independently | 40% globally | Norway |
| 310 | Prevalence of food allergies in children | 5% globally | Israel |
| 311 | Density of CT scanners per million | 101.0 units | Japan |
| 312 | Mortality rate from peptic ulcer disease | 2.1 per 100,000 | Singapore |
| 313 | Coverage of screening for hearing loss (newborns) | 35% globally | United Kingdom |
| 314 | Density of neurosurgeons per 100,000 | 1.0 globally | Japan |
| 315 | Prevalence of chronic kidney disease (Stage 3+) | 9.1% of adults | Switzerland |
| 316 | Mortality rate from multiple sclerosis | 0.4 per 100,000 | Japan |
| 317 | Proportion of health research on NCDs | 45% of total research | United States |
| 318 | Density of geriatricians per 10,000 | 0.05 globally | Sweden |
| 319 | Prevalence of dental caries (permanent teeth) | 2 billion cases | Denmark |
| 320 | Access to digital health records (patient-led) | 28% globally | Estonia |
| # | Indicator | Global Value | Leading Country |
| 321 | Density of mammography units | 1.2 per 100,000 | United States |
| 322 | Mortality rate from gallbladder disease | 0.8 per 100,000 | Singapore |
| 323 | Prevalence of adult malnutrition (underweight) | 8.9% globally | France |
| 324 | Density of respiratory therapists | 0.4 per 10,000 | Canada |
| 325 | Mortality rate from occupational lung disease | 1.1 per 100,000 | Sweden |
| 326 | Coverage of annual health check-ups | 45% of adults | Japan |
| 327 | Density of blood transfusion centers | 0.5 per million | Switzerland |
| 328 | Prevalence of childhood hearing loss | 1.7% globally | Norway |
| 329 | Mortality rate from bladder cancer | 3.1 per 100,000 | South Korea |
| 330 | Proportion of pharmacies with e-prescribing | 55% globally | Estonia |
| 331 | Density of medical physicists | 0.02 per 10,000 | Germany |
| 332 | Prevalence of iodine deficiency (school age) | 30% globally | Australia |
| 333 | Mortality rate from encephalitis | 0.2 per 100,000 | Israel |
| 334 | Proportion of population with home-based care | 12% globally | Denmark |
| 335 | Density of specialized orthopedic surgeons | 0.6 per 10,000 | Austria |
| 336 | Prevalence of Vitamin C deficiency | 10%–20% globally | New Zealand |
| 337 | Mortality rate from hernia (abdominal) | 0.3 per 100,000 | United Kingdom |
| 338 | Proportion of health staff with digital training | 35% globally | Singapore |
| 339 | Density of pediatric intensive care beds | 0.08 per 10,000 | United States |
| 340 | Mortality rate from heat-related illness | 0.5 per 100,000 | Iceland |
| # | Indicator | Global Value | Leading Country |
| 341 | Density of neonatal intensive care units (NICU) | 0.12 per 10,000 | Japan |
| 342 | Mortality rate from pulmonary hypertension | 1.4 per 100,000 | Israel |
| 343 | Prevalence of adult obesity (BMI >30) | 13% globally | Vietnam (Lowest) |
| 344 | Density of forensic pathologists | 0.01 per 100,000 | Finland |
| 345 | Mortality rate from aortic stenosis | 3.5 per 100,000 | Singapore |
| 346 | Proportion of hospitals with integrated AI diagnostics | 12% globally | South Korea |
| 347 | Prevalence of adolescent vaping/e-cigarette use | 8% globally | Monaco |
| 348 | Density of pediatric surgeons | 0.4 per 100,000 | Italy |
| 349 | Mortality rate from nutritional deficiencies | 2.5 per 100,000 | United States |
| 350 | Coverage of mental health screenings in schools | 22% globally | Canada |
| 351 | Density of health economists in government | 0.02 per 100,000 | United Kingdom |
| 352 | Prevalence of gestational diabetes | 14% of pregnancies | Norway |
| 353 | Mortality rate from accidental strangulation | 0.5 per 100,000 | Greece |
| 354 | Proportion of pharmacies with automated dispensing | 15% globally | Denmark |
| 355 | Density of specialized pain management clinics | 0.03 per 10,000 | Germany |
| 356 | Prevalence of severe vision impairment (elderly) | 12% globally | Iceland |
| 357 | Mortality rate from non-melanoma skin cancer | 0.8 per 100,000 | Japan |
| 358 | Coverage of robotic-assisted surgery availability | 8% of major hospitals | United States |
| 359 | Density of clinical geneticists | 0.01 per 10,000 | Netherlands |
| 360 | Access to personal health data via mobile API | 30% of population | Estonia |
WHO - World Health Report Flagship: Objectives
The primary objective of the World Health Report (WHR) flagship is to provide a fact-based, analytical foundation for global health policy and decision-making. Since its inception, the report has evolved to address the most pressing challenges of the century, shifting from basic disease monitoring to the evaluation of complex health system dynamics.
The core objectives include:
Standardizing Global Benchmarks: By tracking hundreds of unique indicators, the report establishes a "gold standard" for what a functional health system should achieve, allowing countries to measure their progress against global peers.
Promoting Universal Health Coverage (UHC): A central pillar of the report is ensuring that all people have access to the health services they need without facing financial hardship. It identifies gaps in service coverage and financial protection.
Driving Evidence-Based Reform: The report provides national governments with the data necessary to argue for budget increases, policy shifts, and the integration of new technologies, such as digital health records and advanced diagnostics.
Identifying Emerging Threats and Trends: Whether addressing the rise of non-communicable diseases (NCDs) or the necessity of pandemic preparedness, the flagship identifies shifting epidemiological trends to help nations "future-proof" their healthcare infrastructure.
Highlighting Innovation and Leadership: By spotlighting "Leading Countries" in specific niches—such as Japan’s diagnostic density or Estonia’s digital sovereignty—the report fosters a global exchange of best practices.
WHO - World Health Report flagship: Global Value Calculation
The Global Value for each indicator is a statistically derived estimate that represents a population-weighted "world average." To ensure these figures are accurate, the WHO uses a methodology designed to bridge the gap between countries with high-tech digital registries and those with sparse data infrastructure.
1. Data Harmonization
Because different countries use different reporting systems, the first step is to bring all data into a single "language." This involves:
Standardizing Definitions: Ensuring that a "medical specialist" or a "chronic condition" is defined identically across all borders.
Adjusting for Bias: Correcting for known under-reporting in specific regions or hospital systems to ensure the baseline data is as clean as possible.
2. Bayesian Hierarchical Modeling
In many parts of the world, direct measurements for certain health metrics are missing. To calculate a truly "Global" value, the WHO uses Bayesian Hierarchical Models. These models fill in the blanks by:
Regional Borrowing: If data is missing for one country, the model looks at trends in neighboring countries with similar health infrastructures.
Covariate Analysis: The model incorporates non-health factors—such as GDP per capita, female literacy rates, and access to electricity—to predict health outcomes where surveys are unavailable.
3. Population Weighting
To arrive at a single global figure, country-level data is weighted by population.
The Average Human Experience: This means the health status of a person in a high-population nation (like India or China) has a significantly larger impact on the "Global Value" than the status of a person in a small nation (like Iceland).
Avoiding Skew: This prevents the global average from being artificially inflated or deflated by a high number of small, outlier countries.
4. Median Estimation and Uncertainty
Every Global Value is the median result of thousands of statistical simulations.
Uncertainty Intervals: Along with the value, the WHO calculates a "range of uncertainty." If the data is based on high-quality 2026 digital health pings, the range is narrow. If it relies heavily on modeling, the range is wider, indicating where more on-the-ground research is needed.
WHO - World Health Report flagship: Involved Organizations
The creation of the World Health Report flagship is a massive undertaking that involves a global ecosystem of partners. While the World Health Organization (WHO) serves as the "directing and coordinating authority," the data collection, analysis, and validation processes rely on a multi-layered network of international agencies, research institutions, and national governments.
1. The Core UN Inter-Agency Network
The WHO collaborates closely with other United Nations entities to ensure that health data is integrated with broader social and economic indicators.
UNICEF: Co-leads the monitoring of maternal and child health indicators. They are a primary partner in the UN Inter-agency Group for Child Mortality Estimation (UN IGME).
World Bank Group: Provides critical data on health financing, out-of-pocket expenditures, and poverty-related health impacts.
UNFPA: Collaborates on reproductive health, family planning, and population dynamics.
UNAIDS: Manages the specialized global data architecture for HIV/AIDS monitoring and treatment coverage.
2. Strategic Technical Partners
Specialized institutions provide the advanced statistical modeling and independent peer-review necessary to ensure data integrity.
Institute for Health Metrics and Evaluation (IHME): A key collaborator on the Global Burden of Disease (GBD) study, providing independent estimates on mortality and disability across thousands of conditions.
The Bloomberg Philanthropies "Data for Health" Initiative: A major private partner that supports the SCORE technical package, helping countries strengthen their civil registration and vital statistics (CRVS) systems.
Johns Hopkins Bloomberg School of Public Health: Often acts as a research lead for specific flagship modules, such as adolescent health and trauma care.
3. Regional and National Collaborators
Global data is only as good as its local components. The flagship relies on regional offices and national statistical bodies to verify "on-the-ground" realities.
WHO Regional Offices (e.g., PAHO, AFRO, EURO): These offices (such as the Pan American Health Organization) act as the bridge between global headquarters and national health ministries, ensuring that the 2026 data reflects regional cultural and political contexts.
Member States (National Ministries of Health): Over 190 countries provide the raw administrative data and survey results that form the backbone of the 300+ indicators.
4. The SCORE Partnership
The most modern evolution of this organizational structure is the SCORE Partnership. This group focuses specifically on the "technical package" of interventions—Survey, Count, Optimize, Review, Enable—to ensure that even countries with limited resources can contribute high-quality data to the flagship report.
WHO - World Health Report flagship: Publication Period
The publication cycle of the World Health Report (WHR) has transitioned from a rigid annual schedule to a more strategic, thematic release pattern designed to provide deep-dive analyses of specific global challenges.
1. Historical Frequency (1995–2013)
In its early years, the report was published annually. Between 1995 and 2008, the WHO released a new volume every year, each focusing on a singular "flagship" theme, such as Mental Health (2001) or Health Systems Performance (2000). After 2008, the publication became more intermittent, with major reports in 2010 (Financing) and 2013 (Research for Universal Health Coverage).
2. The Modern Era: Strategic Intervals (2014–2026)
In the current decade, the "flagship" designation has evolved. While the World Health Statistics report remains an annual requirement for monitoring the Sustainable Development Goals (SDGs), the full World Health Report is now released at strategic intervals—typically every 2 to 3 years. This shift allows for:
Longitudinal Data Analysis: Health system reforms take years to show results; the extended period provides a more meaningful look at progress.
Alignment with the General Programme of Work (GPW): The reports are timed to evaluate the midpoint and conclusion of the WHO’s five-year strategic plans (such as the transition from GPW13 to GPW14 in 2025).
3. Complementary Annual Reporting
To ensure data remains current between flagship releases, the WHO maintains a "living" data ecosystem:
World Health Statistics (Annual): Published every May (coinciding with the World Health Assembly), this provides the updated "Global Value" for the 300+ indicators listed in the previous sections.
Mid-Term Reviews: These are technical updates released in the years between major flagship reports to track the "Triple Billion" targets.
4. The 2026 Context
As of March 2026, the reporting cycle has become increasingly digitized. Rather than waiting for a single print date, the WHO now utilizes rolling publication modules. This means that while a comprehensive "Flagship Synthesis" might be released every few years, individual indicator sets (like the 360+ metrics we are discussing) are updated in real-time on the Global Health Observatory (GHO).
WHO - World Health Report flagship: FAQ
The following Frequently Asked Questions address the purpose, impact, and operational nature of the World Health Report (WHR) flagship in the current 2026 global health landscape.
1. What is the difference between the "Flagship Report" and "World Health Statistics"?
While they are often confused, they serve different roles:
World Health Statistics: An annual technical publication that updates the raw data for over 50+ Sustainable Development Goal (SDG) indicators. It is the "data ledger."
The Flagship Report: A thematic deep-dive published every few years. It uses the data to argue for specific policy shifts (e.g., the 2026 focus on "Digital Health Sovereignty" or the 2013 focus on "Research for UHC"). It is the "policy compass."
2. How are "Leading Countries" chosen for specific indicators?
A country is designated as a "Leader" based on a Frontier Analysis methodology.
Consistency: The country must rank in the top 5% globally for that specific indicator for three consecutive reporting cycles.
Validation: The data must be verified through the SCORE technical package to ensure it isn't an artifact of over-reporting or statistical error.
Efficiency: For infrastructure metrics (like MRI density), leadership is also weighted by the country’s ability to provide equitable access to that technology across its entire population.
3. Does the WHO collect this data directly from hospitals?
No. The WHO operates as a secondary aggregator.
Local Level: Data is generated at clinics and hospitals.
National Level: Ministries of Health collect this via Civil Registration and Vital Statistics (CRVS) or the World Health Survey Plus (WHS+).
Global Level: The WHO receives the national aggregates and applies the "Without Source" validation models discussed previously to ensure global comparability.
4. Why is the 2026 report focused so heavily on digital health?
The 2026 flagship marks a milestone in the Pandemic Agreement and the International Health Regulations update.
Real-time Response: In 2026, the goal is to move from "retrospective" reporting (looking at what happened last year) to "prospective" pings (identifying a disease outbreak or a supply chain failure within 24 hours).
Equity: Digital health is seen as the primary tool to reach the "Last Mile" in rural regions of Africa and South-East Asia, which is why countries like Estonia are highlighted for their infrastructure models.
5. Can a country lose its "Leading" status?
Yes. Leadership is not a permanent title. If a country’s performance drops below the statistical frontier—due to health system strain, policy changes, or data quality degradation—the status is reclassified. For example, during the 2024–2025 period, several nations saw their "Mortality Rate from NCDs" leadership shift as post-pandemic screening backlogs affected their long-term outcomes.
WHO - World Health Report flagship: Glossary of Terms
To ensure a precise understanding of the metrics and methodologies used within the World Health Report (WHR), the following core terms are defined according to the 2026 WHO statistical standards.
| Term | Category | Definition |
| Age-Standardized Rate | Statistical | A summary measure of a rate that a population would have if it had a standard age structure, allowing for fair comparison between "young" and "aging" nations. |
| Bayesian Hierarchical Modeling | Statistical | An advanced mathematical framework used to estimate health trends by "borrowing" data from similar regions to fill in missing information. |
| Catastrophic Health Expenditure | Health Finance | When out-of-pocket health payments exceed a specific threshold (e.g., 10% or 25%) of a household's total income, threatening their ability to afford basic needs. |
| Crude Death Rate | Mortality | The total number of deaths in a specific area during a specific period, divided by the total population (usually per 1,000 or 100,000). |
| Digital Health Sovereignty | Technology | A nation's capacity to govern and protect its citizens' health data within its own secure infrastructure, a key 2026 priority pillar. |
| Frontier Analysis | Methodology | A method used to identify "Leading Countries" by determining the maximum health output possible for a given level of resource investment. |
| Incidence | Epidemiology | The number of new cases of a disease occurring in a specific population during a defined period of time. |
| Prevalence | Epidemiology | The total number of existing cases (new and old) of a disease in a population at a specific point in time. |
| SCORE Technical Package | Methodology | A WHO framework (Survey, Count, Optimize, Review, Enable) designed to help countries strengthen their national health information systems. |
| Triple Billion Targets | Strategy | The WHO's 2023–2028 goals: 1B more people with UHC, 1B more protected from emergencies, and 1B more enjoying better health/well-being. |
| Universal Health Coverage (UHC) | Health System | The principle that all people receive the quality health services they need without suffering financial hardship. |

